Agonists of Peroxisome Proliferator-Activated Receptor γ Inhibit Cell Growth in Malignant Melanoma-Reference-Cited by-同舟云学术

Agonists of Peroxisome Proliferator-Activated Receptor γ Inhibit Cell Growth in Malignant Melanoma

Published:2002-09 Issue:3 Volume:119 Page:576-582
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Mössner Rotraut,Schulz Ulrike,Krüger Ullrich,Neumann Christine,Reich Kristian,Middel Peter,Schinner Sven,Füzesi László

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference30 articles.

1. PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A;Altiok;Genes Dev,1997

2. Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, October 24–26, 1983;Anonymous;J Am Acad Dermatol,1984

3. Expression of peroxisome proliferator activated receptors (PPARs) in human hair follicles and PPAR alpha involvement in hair growth;Billoni;Acta Derm Venereol,2000

4. Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology;Blaschke;J Immunol Meth,2000

5. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer;Chang;Cancer Res,2000

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peroxisome proliferator-activated receptors: Key regulators of tumor progression and growth;Translational Oncology;2024-09

2. Computational Techniques for Drug Repurposing: A Paradigm Shift in Drug Discovery;Current Drug Therapy;2023-08

3. PPARs and the Kynurenine Pathway in Melanoma—Potential Biological Interactions;International Journal of Molecular Sciences;2023-02-04

4. The efficacy and safety of pioglitazone in psoriasis vulgaris;Medicine;2020-08-07

5. Pioglitazone as a modulator of the chemoresistance of renal cell adenocarcinoma to methotrexate;Oncology Reports;2020-01-29